StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
SCLX

Scilex Holding Company

SCLX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$6.56
-0.04 -0.61%

Key statistics

from XBRL data in SEC filings
Market cap
$55.7M
Revenue (TTM)
$33.9M
Net income (TTM)
-$394M
EPS (TTM)
$-40.50
P/E ratio
Dividend yield
Free cash flow
$3.68M
Cash
$3.35M
Total assets
$294M
Gross margin
371.5%
52-week range
$2.62 – $21.34

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Completed an acquisition or disposition Jul 22, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Jun 29, 2026 8-K Shareholder vote results Jun 24, 2026 10-Q Quarter ended 2026-03-31 May 20, 2026 8-K Other events May 11, 2026 8-K Entered a material agreement; Regulation FD disclosure May 5, 2026 8-K Entered a material agreement Apr 28, 2026 10-K Fiscal year ended 2025-12-31 Apr 10, 2026 8-K Regulation FD disclosure Mar 13, 2026 8-K Regulation FD disclosure Mar 13, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 20, 2026 8-K Modified rights of security holders; Amended charter or bylaws Feb 3, 2026 8-K Entered a material agreement Feb 2, 2026 8-K Regulation FD disclosure Dec 30, 2025 8-K Regulation FD disclosure Dec 22, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 17, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 12, 2025 8-K Director or officer change; Shareholder vote results Dec 11, 2025 8-K Entered a material agreement; Took on a direct financial obligation Dec 5, 2025 8-K Completed an acquisition or disposition; Regulation FD disclosure Dec 1, 2025 8-K Entered a material agreement; Unregistered sale of equity Nov 24, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 4, 2025 8-K Terminated a material agreement Oct 31, 2025 8-K Director or officer change Oct 7, 2025 8-K Entered a material agreement; Unregistered sale of equity Oct 1, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Sep 26, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure; Other events Sep 26, 2025 8-K Director or officer change Sep 26, 2025 8-K Director or officer change Aug 21, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement Jul 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 23, 2025 8-K Regulation FD disclosure Jun 23, 2025 8-K Shareholder vote results Jun 23, 2025 8-K Regulation FD disclosure Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Director or officer change May 12, 2025 8-K Other events Apr 30, 2025